Invest now

Q-line Biotech Cash Flow Annual

BSE: - | NSE: QLINE | ISIN: INE1G2W01011 | Sector: Biotechnology & Drugs
595.30 -16.35 (-2.67%)Updated : 15 Oct 2026
Research on
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net 68.0423.2630.20-
Net Changein Cash -7.07-51.8825.06-
Cash Taxes Paid 6.869.2612.43-
Net Income/ Starting Line 44.1930.6129.84-
Changesin Working Capital -33.64-63.64-9.75-
Cashfrom Operating Activities -2.64-48.3649.94-
Cashfrom Financing Activities 106.6833.9752.81-
Issuance( Retirement)of Stock Net 0.000.000.00-
Depreciation/ Depletion 7.323.932.14-
Other Investing Cash Flow Items Total -2.834.21-0.05-
Capital Expenditures -56.26-48.90-26.27-
period Type ----
Non- Cash Items -19.204.922.74-
Financing Cash Flow Items -14.70-6.28-3.80-
period Length 12.0012.0012.00-
Cashfrom Investing Activities -118.18-89.38-52.63-
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,035.00+40.00(4.02%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)